Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

4.60
Delayed Data
As of 3:59pm ET
 +0.05 / +1.10%
Today’s Change
2.40
Today|||52-Week Range
6.45
+46.03%
Year-to-Date

Today’s Trading

Previous close4.55
Today’s open4.55
Day’s range4.48 - 4.90
Volume508,434
Average volume (3 months)1,095,842
Market cap$142.6M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-15.53%
Earnings growth (this year)+43.70%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales8.52
Price/Book3.96

Competitors

 Today’s
change
Today’s
% change
TRVNTrevena Inc-0.04-1.68%
REPHRecro Pharma Inc-0.05-0.68%
MNKDMannKind Corp+0.06+4.29%
PPHMPeregrine Pharmaceut...+0.15+4.87%
Data as of 3:59pm ET, 08/18/2017

Financials

Last reporting dateAugust 14, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$6.5M
Annual profit (last year)-$19.4M
Net profit margin-300.24%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Dennis J. Carlo
Vice President-
Operations
Karen K. Daniels
Corporate headquarters
San Diego, California

Forecasts